Kissable Diabetics Foot Cream recalled nationwide for inadequate release testing
Brands International Corporation is recalling Kissable Diabetics Foot Cream nationwide due to lack of adequate release testing during manufacturing. The FDA has classified this as a Class II recall.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for a manufacturing process deviation related to inadequate release testing. No illnesses or injuries have been reported, and the issue is compliance-related rather than a confirmed safety threat. This warrants a Moderate classification per the rubric criteria for voluntary precautionary recalls.
Plain-English summary
Brands International Corporation is recalling Kissable Diabetics Foot Cream, a topical foot cream sold in 4 oz (113 g) tubes and manufactured in Newmarket, Ontario, Canada. The product is distributed nationwide in the United States.
The recall has been issued due to manufacturing deviations involving lack of adequate release testing. The FDA has classified this as a Class II recall.
The affected product includes multiple lot numbers, all within their expiration dates: 23319025, 23318024, 23313023, 23311022, 23310021, 23222021, 23220020, 23215019, 23215018, 23214017, 23213016, 23208015, 2313014, 2312213, 2312212, 2312111, 2312110, 2311709, 2311708, 2311607, 2311506, 2311405, 2307904, 23073003, 23072002, 2306901, and 24135003.
Consumers who have purchased Kissable Diabetics Foot Cream should stop using the product. Those with questions should contact Brands International Corporation regarding returns or replacements.
The recalled product
- Product
- Kissable Diabetics Foot Cream, NET WT 4 oz (113 g) per tube, Manufactured By: Brands International Corp., Newmarket, ON, L3X 2S2. UPC 6 72008 80925 3
- Manufacturer
- Brands International Corporation
- Category
- Drug — Topical / Foot Care
- Hazard
- cgmp-deviation
- inadequate-release-testing
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lots: 23319025
- 23318024
- 23313023
- 23311022
- 23310021
- 23222021
- 23220020
- 23215019
- 23215018
- 23214017
- 23213016
- 23208015
- 2313014
- 2312213
- 2312212
- 2312111
- 2312110
- 2311709
- 2311708
- 2311607
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27